TNIK

protein-coding

TRAF2 and NCK interacting kinase, the group of MicroRNA protein coding host genes

Gene summary

Wnt signaling plays important roles in carcinogenesis and embryonic development. The protein encoded by this gene is a serine/threonine kinase that functions as an activator of the Wnt signaling pathway. Mutations in this gene are associated with an autosomal recessive form of cognitive disability. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2017]

MANE transcript

NM_015028.4

Inheritance

AR

ClinVar variants

P:1U:161B:42

Top phenotype

Intellectual developmental disorder, autosomal recessive 54

gnomAD constraint

pLI —, LoF o/e 0.1

Max pathogenic AF

—

Genomic locus

chr3:171,058,414-171,460,408

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~402.0 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

intellectual developmental disorder, autosomal recessive 54LIMITED

Inheritance Pattern: Unknown

Disease ID:MONDO:0014876

Submitter: Labcorp Genetics (formerly Invitae)

intellectual developmental disorder, autosomal recessive 54LIMITED

Inheritance Pattern: AR

Disease ID:MONDO:0014876

Submitter: Ambry Genetics

autosomal recessive non-syndromic intellectual disabilitySUPPORTIVE

Inheritance Pattern: AR

Disease ID:MONDO:0019502

Submitter: Orphanet

intellectual developmental disorder, autosomal recessive 54MODERATE

Inheritance Pattern: AR

Disease ID:MONDO:0014876

Submitter: PanelApp Australia

non-syndromic intellectual disabilityLIMITED

Inheritance Pattern: AR

Disease ID:MONDO:0000509

Submitter: ClinGen

*TNIK* encodes the TRAF2 and NCK-interacting protein kinase involved in dendrite development and synaptic transmission. *TNIK* was first reported in relation to autosomal recessive non-syndromic intellectual disability in 2016 (Anazi et al., PMID: 27106596). A homozygous nonsense variant (p.Arg180*) was reported in two multiplex, consanguineous Saudi Arabian families with five affected males, and was determined to be a founder variant. Affected individuals exhibit intellectual disability, speech delay, and hyperactivity. Western blot analysis of patient cells showed absence of the TNIK protein. The mechanism of pathogenicity is loss of function. This gene-disease relationship is also supported by experimental evidence, including functional alterations in human cells, and a mouse model. TNIK functions as a postsynaptic density (PSD) signaling hub, and *TNIK* mutations in hiPSC-derived excitatory neurons have been shown to disrupt immature synapse function and impair MAPK-dependent phosphorylation of core PSD proteins (PMID: 38638602). *Tnik* knock-out mice show impairments in dentate gyrus neurogenesis, cognitive deficits, and hyperlocomotor behavior (PMID: 23035106). In summary, there is limited evidence supporting the relationship between *TNIK* and autosomal recessive non-syndromic intellectual disability. While more evidence is needed to establish this relationship definitively, no convincing contradictory evidence has emerged. The classification was downgraded from moderate to limited because only two families with the same founder variant have been reported since 2016. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on August 6, 2025 (SOP Version 12).

intellectual developmental disorder, autosomal recessive 54LIMITED

Inheritance Pattern: AR

Disease ID:MONDO:0014876

Submitter: Illumina

Clinical Genomic Database (CGD)

Intellectual developmental disorder, autosomal recessive 54AR

Manifestation: Neurologic

Intervention: General

Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing

Refs: 27106596Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to TNIK variants in ClinVar

5 Conditions Cataloged
not specifiedTotal: 141
not providedTotal: 53
Intellectual disability, autosomal recessive 54Total: 13
TNIK-related disorderTotal: 13
See casesTotal: 1

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_015028.4. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
6
clinvar
38
clinvar
2
clinvar
46
missense
140
clinvar
2
clinvar
142
nonsense
1
clinvar
4
clinvar
5
start loss
0
frameshift
1
clinvar
1
splice donor/acceptor (+/-2bp)
10
clinvar
10
Total10161402204
Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 28 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_015028.4RefSeqNP_055843.133MANE Select
ENST00000436636.7EnsemblENSP00000399511.233MANE Select
NM_001161560.3RefSeqNP_001155032.132Standard
NM_001161561.3RefSeqNP_001155033.132Standard

Model Organisms & Knockout Phenotypes

Observed phenotypic effects in mouse and zebrafish models

Gene / ModelOrganismObserved Phenotype
tnikaDanio rerio

Structure: EVL

Quality: structure

abnormal

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Oxidative Stress Induced Senescence
  • Oxidative Stress Induced Senescence
  • Cellular Senescence
  • Cellular responses to stress
  • Cellular responses to external stimuli

Biological Process

  • MAPK cascade
  • positive regulation of protein phosphorylation
  • protein phosphorylation
  • cytoskeleton organization
  • activation of JNKK activity

Molecular Function

  • protein kinase activity
  • protein serine/threonine kinase activity
  • protein binding
  • ATP binding

Cellular Component

  • nucleus
  • nucleoplasm
  • cytoplasm
  • cytosol
  • cytoskeleton

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000436636
Coding exons
33
Length
399070
Individuals with no LoFs
124696
Homozygous LoFs
0
Heterozygous LoFs
13
Defined
124709
p
0.0000521
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense4.104367530.5790.00004278865
Missense (PolyPhen)160294.460.543363558
Synonymous0.4232622710.9670.00001482555
Loss of Function7.75987.00.1030.00000533945

Population LoF Frequency

PopulationCAFp-valueStatus
African00.0absent
Latino/Admixed American0.0000880.000087rare
Ashkenazi Jewish00.0absent
East Asian0.0000560.000056rare
Finnish0.0000460.000046rare
European (Non-Finnish)0.0000720.000071rare
South Asian00.0absent
Other00.0absent

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Serine/threonine kinase that acts as an essential activator of the Wnt signaling pathway. Recruited to promoters of Wnt target genes and required to activate their expression. May act by phosphorylating TCF4/TCF7L2. Appears to act upstream of the JUN N-terminal pathway. May play a role in the response to environmental stress. Part of a signaling complex composed of NEDD4, RAP2A and TNIK which regulates neuronal dendrite extension and arborization during development. More generally, it may play a role in cytoskeletal rearrangements and regulate cell spreading. Phosphorylates SMAD1 on Thr-322. {ECO:0000269|PubMed:10521462, ECO:0000269|PubMed:15342639, ECO:0000269|PubMed:19061864, ECO:0000269|PubMed:19816403, ECO:0000269|PubMed:20159449, ECO:0000269|PubMed:21690388}.;
Disease
DISEASE: Mental retardation, autosomal recessive 54 (MRT54) [MIM:617028]: A form of mental retardation, a disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRT54 patients manifest intellectual disability, delayed speech and hyperactivity. {ECO:0000269|PubMed:27106596}. Note=The disease may be caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.188

Intolerance Scores

LoFtool
0.467
RVIS EVS
-1.44
RVIS percentile EVS
3.97

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
N
Indispensability pred.
E
Indispensability score
0.978

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.